State of Florida and Cordis Announce Planned Investment
By Azmed Devices Editorial Team
Cordis announced a $60 million investment in its Miami Lakes headquarters to expand operations and create up to 300 new full-time jobs. This initiative supports the company's long-standing history of cardiovascular innovation in the region.
According to Cordis, the company is planning a $60 million investment at its corporate headquarters located in Miami Lakes, Florida. This capital injection is expected to support the creation of up to 300 new full-time positions over the coming years. The state government has supported this initiative by awarding a grant through its High Impact Performance Incentive Program, which aims to enhance the company's internal operational, engineering, and manufacturing capabilities.
Secretary of Commerce J. Alex Kelly stated that the expansion reinforces Florida's status as a hub for medical technology and advanced manufacturing. Cordis leadership expressed that the project builds upon the company's nearly 70-year history in the region. By reinvesting in its headquarters and research and development facilities, the organization intends to leverage the local workforce to continue its mission of advancing cardiovascular care technologies for millions of global patients.
Cordis officials noted that the Miami Lakes site remains a critical location for the company's development of new cardiovascular solutions. The investment is intended to sustain a legacy of technical expertise and long-term employment in the area. By expanding its operational footprint, the firm aims to maintain its position as a global leader in the field, focusing on improving clinical outcomes through internal development, strategic partnerships, and ongoing innovation in medical device manufacturing.
Source
This article summarizes an official Cordis announcement. Read the original at https://cordis.com/emea/news/state-of-florida-and-cordis-announce-planned-investment. Product availability in Azerbaijan is subject to local registration; contact Azmed Devices for current status.
